# Filing Detail

Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001193125-26-201458
Filing Date
2026-05-01
Accepted
2026-05-01 16:14:08
Documents
23

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 424B4 | d50309d424b4.htm | 424B4 | 2157671
2 | GRAPHIC | g50309g05a01.jpg | GRAPHIC | 110556
3 | GRAPHIC | g50309g06a01.jpg | GRAPHIC | 123687
4 | GRAPHIC | g50309g06a02.jpg | GRAPHIC | 114612
5 | GRAPHIC | g50309g07a01.jpg | GRAPHIC | 95640
6 | GRAPHIC | g50309g16g01.jpg | GRAPHIC | 135286
7 | GRAPHIC | g50309g16g02.jpg | GRAPHIC | 231793
8 | GRAPHIC | g50309g16k00.jpg | GRAPHIC | 104078
9 | GRAPHIC | g50309g16k02.jpg | GRAPHIC | 72597
10 | GRAPHIC | g50309g19r25.jpg | GRAPHIC | 127334
11 | GRAPHIC | g50309g36y62.jpg | GRAPHIC | 109260
12 | GRAPHIC | g50309g62g77.jpg | GRAPHIC | 55595
13 | GRAPHIC | g50309g64w16.jpg | GRAPHIC | 192050
14 | GRAPHIC | g50309g77z52.jpg | GRAPHIC | 144979
15 | GRAPHIC | g50309g84u21.jpg | GRAPHIC | 115475
16 | GRAPHIC | g50309g89f01.jpg | GRAPHIC | 317910
17 | GRAPHIC | g50309g89f02.jpg | GRAPHIC | 125450
18 | GRAPHIC | g50309g89f03.jpg | GRAPHIC | 160086
19 | GRAPHIC | g50309g89f04.jpg | GRAPHIC | 55887
20 | GRAPHIC | g50309g89f05.jpg | GRAPHIC | 183197
21 | GRAPHIC | g50309g89f06.jpg | GRAPHIC | 139364
22 | GRAPHIC | g50309g89f07.jpg | GRAPHIC | 124029
23 | GRAPHIC | g50309g89f08.jpg | GRAPHIC | 132163
| Complete submission text file | 0001193125-26-201458.txt |  | 6236922

Mailing Address 101 MAIN STREET SUITE 1220 CAMBRIDGE MA 02142
Business Address 101 MAIN STREET SUITE 1220 CAMBRIDGE MA 02142 45 2138 7627
Hemab Therapeutics Holdings, Inc. (Filer) CIK: 0002114044 (see all company filings)

EIN.: 414241952 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-294989 | Film No.: 26932689
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)